Novaliq GmbH is a drug delivery company located in the Heidelberg Technology Park, Germany. They develop innovative pharmaceutical formulations based on semifluorinated alkanes (SFAs). The company currently develops novel ophthalmic and dermatological products as well as solutions for organ preservation, based on the unique physicochemical properties of SFA. The company also provides CyclASol, a non-aqueous formulation containing cyclosporine to treat dry eye syndrome. Novaliq GmbH was founded in 2004.